CGRP2 activators represent a diverse class of exogenous compounds capable of upregulating CGRP2 gene expression. Despite variations in structure, these activators converge upon stimulating CGRP2 transcription through distinct molecular mechanisms. Many CGRP2 activators mediate their effects by binding specific intracellular receptors. Receptor engagement induces conformational changes recruiting cofactors to targeted sequences within the CGRP2 promoter region. Bound cofactors then modify local chromatin configuration, improving accessibility for basal transcription factors. Alternatively, some activators mobilize intracellular signaling networks through receptor crosstalk. These signals modify activities of DNA-binding transcriptional regulators via post-translational adjustments.
Additionally, certain CGRP2 activators may exert indirect influences through disrupting general cellular processes tied to controlling CGRP2 expression levels. Interfering with homeostatic signaling, stress response pathways or epigenetic controls can secondarily remodel the local milieu of transcriptional regulation over the CGRP2 gene. Regardless of the distinct strategies employed, CGRP2 activators function genomically to amplify production of CGRP2 mRNA and protein across cell types. Elucidating their diverse modes of stimulatory action has furthered understanding of transcriptional mechanisms governing this calcitonin receptor subunit.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol forms ER complexes recruiting cofactors to restructure chromatin at the CGRP2 promoter, enabling transcription initiation protein binding and mRNA synthesis. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II activates EGFR signaling cascades that modify activities of ELK1 and related factors, permitting interaction with Ets sites to drive CGRP2 expression. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
AA stimulates PKC and MAPK cascades changing activities of transcriptional regulators like ELK1. These factors bind promoter sites controlling CGRP2 expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
RA activates RAR:RXR heterodimers binding RARE elements in the CGRP2 promoter region to initiate its expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin activates PKA phosphorylating CREB. Phosphorylated CREB binds CRE consensus sequences augmenting CGRP2 gene transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol induces SIRT1 altering histone modifications around the CGRP2 locus allowing activator protein binding. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
VPA inhibits HDAC activity modifying chromatin structure permitting factor assembly over CGRP2 promoter regions. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyric acid is an HDAC inhibitor that remodels chromatin positioning near the CGRP2 promoter enabling transcription initiation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dex as a GR agonist stimulates GR dimer formation facilitating interactions with promoter GRE elements. | ||||||